RBC Life Sciences, Inc. (RBCL)

Market Cap	4.22K
Revenue (ttm)	24.12M
Net Income (ttm)	-559.51K
Shares Out	42.21M
EPS (ttm)	-0.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,700
Average Volume	2,634
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0001
Beta	-15.12
RSI	35.32
Earnings Date	n/a

About RBC Life Sciences

RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company’s Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of rese...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1988
• Employees: 89
• Stock Exchange: OTCMKTS
• Ticker Symbol: RBCL

Financial Performance

In 2014, RBC Life Sciences's revenue was $28.27 million, an increase of 10.99% compared to the previous year's $25.47 million. Losses were -$602,811, 20.6% more than in 2013.